Retrospective analysis of the safety and efficacy of vandetanib as systemic treatment for patients with advanced and progressive medullary thyroid cancer (MTC).
Jaume Capdevila
No relevant relationships to disclose
Javier Martinez-Trufero
No relevant relationships to disclose
Elsa Dalmau
No relevant relationships to disclose
Cristina Alvarez-Escola
No relevant relationships to disclose
Miguel Beltran
No relevant relationships to disclose
Manuel Duran
No relevant relationships to disclose
Isabel Gallegos
No relevant relationships to disclose
Jose Luis Manzano
No relevant relationships to disclose
Ricard Mesia
No relevant relationships to disclose
Isabel Pajares
No relevant relationships to disclose
Jose Fuentes Pradera
No relevant relationships to disclose
Juan J. Grau
No relevant relationships to disclose
Òscar Reig
No relevant relationships to disclose
Jose Manuel Trigo
No relevant relationships to disclose
Enrique Grande
No relevant relationships to disclose